Watch LTGO. Know when insiders buy.
One email the day a filing lands. Free.
LTGO
Latigo Biotherapeutics, Inc.
16.34
+1.09 +7.15%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.1BP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME —NET CASH —52W 14.00 – 25.00SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$25.8M | −$25.8M | — | -27.59 | — | — | — | Sep 3 |
| Q1 2026 · Mar 31 | — | — | — | — | −$23M | — | — | — | — | — | Sep 3 |
| Q2 2025 · Jun 30 | — | — | — | −$25.7M | −$25.8M | — | -36.52 | — | — | — | Sep 3 |
| Q1 2025 · Mar 31 | — | — | — | — | −$21M | — | — | — | — | — | Sep 3 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | — | — | — | — | — | — | — | — | — |
Every number comes from Latigo Biotherapeutics, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.